Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Higuchi

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Psychiatry|November 17, 2006
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trialHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Human Psychopharmacology|January 4, 2008
Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case seriesHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Clinical Neuropharmacology|October 2, 2003
Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reportsHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
International Journal of General Medicine|August 17, 2011
Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depressionKeiichiro Tominaga, Mioto Okazaki, Hisashi Higuchi, et al.
Journal of Affective Disorders|September 16, 2011
Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorderMitsuhiro Kamata, Akihito Suzuki, Keizo Yoshida, et al.
Human Psychopharmacology|August 11, 2004
Milnacipran treatment of a terminally ill cancer patient with major depressive disorderKazuhiro Sato, Hisashi Higuchi, Keizo Yoshida, et al.
Neuropsychiatric Disease and Treatment|June 28, 2017
Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depressionHitoshi Takahashi, Hisashi Higuchi, Kazuhiro Sato, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|July 2, 2003
High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasmaTadashi Ohkubo, Ritsuko Shimoyama, Koichi Otani, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patientsHisashi Higuchi, Kazuhiro Sato, Shingo Naito, et al.
Neuropsychobiology|November 1, 2014
Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depressionHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Psychiatry|November 17, 2006
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trialHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Human Psychopharmacology|January 4, 2008
Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case seriesHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Clinical Neuropharmacology|October 2, 2003
Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reportsHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
International Journal of General Medicine|August 17, 2011
Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depressionKeiichiro Tominaga, Mioto Okazaki, Hisashi Higuchi, et al.
Journal of Affective Disorders|September 16, 2011
Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorderMitsuhiro Kamata, Akihito Suzuki, Keizo Yoshida, et al.
Human Psychopharmacology|August 11, 2004
Milnacipran treatment of a terminally ill cancer patient with major depressive disorderKazuhiro Sato, Hisashi Higuchi, Keizo Yoshida, et al.
Neuropsychiatric Disease and Treatment|June 28, 2017
Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depressionHitoshi Takahashi, Hisashi Higuchi, Kazuhiro Sato, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|July 2, 2003
High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasmaTadashi Ohkubo, Ritsuko Shimoyama, Koichi Otani, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patientsHisashi Higuchi, Kazuhiro Sato, Shingo Naito, et al.
Neuropsychobiology|November 1, 2014
Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depressionHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
Pageof 6